ExploreWatchlistsPricing
  1. US-listed companies
  2. IMMUNIC, INC.
  3. Financials
  4. Stockholders' equity

IMMUNIC, INC. (IMUX)

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 2025-7-136.21%
Dec 31, 202418-36.30%
Dec 31, 202329-74.55%
Dec 31, 2022114-10.57%
Dec 31, 2021127-19.95%
Dec 31, 2020159+172.06%
Dec 31, 201958+369.65%
Dec 31, 201812-75.17%
Dec 31, 201750-14.38%
Dec 31, 201658-29.01%
Dec 31, 201582-15.62%
Dec 31, 201498

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat